Literature DB >> 21475329

Is chemotherapy associated with cognitive impairment?

Robert Zachariae1, Mimi Yung Mehlsen.   

Abstract

Cancer survivors often report difficulties with memory and concentration—sometimes referred to by patients as "chemobrain" or "chemofog". The results from two recent studies suggest that, while chemotherapy itself may not be associated with cognitive impairment, some patients might already be experiencing cognitive difficulties before treatment is even started.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21475329     DOI: 10.1038/nrurol.2011.29

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  9 in total

1.  A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function.

Authors:  Catherine E Jansen; Christine Miaskowski; Marylin Dodd; Glenna Dowling; Joel Kramer
Journal:  Cancer       Date:  2005-11-15       Impact factor: 6.860

2.  A prospective study of neuropsychological functioning in testicular cancer patients.

Authors:  T Skaali; S D Fosså; S Andersson; M Cvancarova; C W Langberg; G Lehne; A A Dahl
Journal:  Ann Oncol       Date:  2010-11-03       Impact factor: 32.976

3.  Cognitive impairment in men with testicular cancer prior to adjuvant therapy.

Authors:  Jeffrey S Wefel; Damon J Vidrine; Tracy L Veramonti; Christina A Meyers; Salma K Marani; Harald J Hoekstra; Josette E H M Hoekstra-Weebers; Lokesh Shahani; Ellen R Gritz
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

4.  Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.

Authors:  Kerstin Hermelink; Helmut Küchenhoff; Michael Untch; Ingo Bauerfeind; Michael Patrick Lux; Markus Bühner; Juliane Manitz; Veronika Fensterer; Karin Münzel
Journal:  Psychooncology       Date:  2010-12       Impact factor: 3.894

5.  Long-term cognitive function following chemotherapy in patients with testicular cancer.

Authors:  Anders Degn Pedersen; Philip Rossen; Mimi Yung Mehlsen; Christina Gundgaard Pedersen; Robert Zachariae; Hans von der Maase
Journal:  J Int Neuropsychol Soc       Date:  2009-02-10       Impact factor: 2.892

6.  Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.

Authors:  Sanne B Schagen; Willem Boogerd; Martin J Muller; Wim Ten Bokkel Huinink; Luc Moonen; Wim Meinhardt; Frits S A M Van Dam
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

7.  The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.

Authors:  Sanne B Schagen; Enny Das; Frits S A M van Dam
Journal:  Psychooncology       Date:  2009-06       Impact factor: 3.894

8.  Cognitive function in breast cancer patients prior to adjuvant treatment.

Authors:  Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Charlotte T Furstenberg; Bernard F Cole; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872

9.  A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

Authors:  V Jenkins; V Shilling; G Deutsch; D Bloomfield; R Morris; S Allan; H Bishop; N Hodson; S Mitra; G Sadler; E Shah; R Stein; S Whitehead; J Winstanley
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

  9 in total
  5 in total

1.  Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment.

Authors:  Ali Amidi; Lisa M Wu; Anders Degn Pedersen; Mimi Mehlsen; Christina Gundgaard Pedersen; Philip Rossen; Mads Agerbæk; Robert Zachariae
Journal:  Support Care Cancer       Date:  2015-02-26       Impact factor: 3.603

2.  Chronic cladribine administration increases amyloid beta peptide generation and plaque burden in mice.

Authors:  Crystal D Hayes; Debleena Dey; Juan Pablo Palavicini; Hongjie Wang; Wataru Araki; Madepalli K Lakshmana
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

3.  Reliability and validity of the CogState battery Chinese language version in schizophrenia.

Authors:  Na Zhong; Haifeng Jiang; Jin Wu; Hong Chen; Shuxing Lin; Yan Zhao; Jiang Du; Xiancang Ma; Ce Chen; Chengge Gao; Kenji Hashimoto; Min Zhao
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

4.  A meta-analysis of cognitive impairment following adult cancer chemotherapy.

Authors:  Oana C Lindner; Bob Phillips; Martin G McCabe; Andrew Mayes; Alison Wearden; Filippo Varese; Deborah Talmi
Journal:  Neuropsychology       Date:  2014-03-17       Impact factor: 3.295

Review 5.  FORECAST - A cloud-based personalized intelligent virtual coaching platform for the well-being of cancer patients.

Authors:  Sofoklis Kyriazakos; Vincenzo Valentini; Alfredo Cesario; Robert Zachariae
Journal:  Clin Transl Radiat Oncol       Date:  2017-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.